WHO ICTRP trial
A study of CMV-TCR-T cells in the treatment of refractory CMVemia after HSCT
ChiCTR2100042272 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100042272 |
|---|---|
| Public title | A study of CMV-TCR-T cells in the treatment of refractory CMVemia after HSCT |
| Scientific title | A study of CMV-TCR-T cells in the treatment of refractory CMVemia after HSCT |
| Primary sponsor | Peking University People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Patients with refractory CMVemia after allogeneic hematopoietic stem cell transplantation |
| Interventions | Experimental group: infusion the TCR-T cells |
| Registration date | Jan 17, 2021 |
| Target size | Experimental group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: